
Pharma Pulse 9/4/24: AI Potential in Budgeting and Forecasting, Digital Twins Could Be Crystal Balls of Healthcare & more
The latest news for pharma industry insiders.
In the final part of this video interview, Jim Murphy, CEO of Greenphire discusses the role of artificial intelligence, using trusted data, and simplifying protocols.
Individualized digital twins offer the prospect of better predicting individual patients’ disease progression and response to therapy.
When I set out to improve my tainted reputation with chatbots, I discovered a new world of AI manipulation.
Rite Aid Corporation (“Rite Aid” or the “Company”) announced that Matt Schroeder has been appointed Chief Executive Officer after the Company’s emergence from Chapter 11. Mr. Schroeder joined Rite Aid in 2000 and most recently served as the Company’s Chief Financial Officer. He succeeds Jeffrey S. Stein.
Is your Market Access team reaching its full potential, or are outdated processes holding it back?
In an exclusive article for Pharmaceutical Executive Brand Insights, Cameron Izadi, SVP, at Fingerpaint Market Access, shares three transformative strategies to help you rethink your approach, unlock capabilities, and boost brand performance.
Read Cameron's insights and start positioning your brand for success: https://bit.ly/47aHa0i
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor 
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

